Type of security: Stock
Sector: Health Care
Industry: Major Pharmaceuticals
The data is delayed by 15 minutes.
Description: Endo International plc, a specialty healthcare company, develops, manufactures, markets, and distributes branded pharmaceutical and generic products, and medical devices worldwide. It provides branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar, and Fortesta Gel to treat and manage pain and conditions in urology, endocrinology, and oncology. The company also offers non-branded generic products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women?s health, and hypertension markets; and pharmaceutical products in the areas of ADHD, pain, urology, and allergy. In addition, it provides various medical devices comprising AMS 700 MS series, AMS 800 artificial urinary sphincters, GreenLight XPS laser systems, Elevate anterior and posterior pelvic floor repair systems, and Monarc subfascial hammock products in the areas of men?s and women?s health, and prostate health. The company?s products also inc
See how to gain 20% in 14 sec with TrendsInvesting
|Shares Outstanding||EPS||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||-1.55%||Sales Growth - 4 Quarters||-15.23%||Sales Growth - Q/Q||-10.73%||P/E|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||-2.55%||ROE||-8.7%||ROI||-3.62%|
|Current Ratio||1.55||Quick Ratio||1.37||Long Term Debt/Equity||2.86||Debt Ratio||0.83|
|Gross Margin||49.62%||Operating Margin||-27.98%||Net Profit Margin||-11.54%||Dividend Payout Ratio|
|Cash From Financing Activities||Cash From Investing Activities||996.86 M||Cash From Operating Activities||-930.48 M||Gross Profit||329.86 M|
|Net Profit||-89.81 M||Operating Profit||45.75 M||Total Assets||14.15 B||Total Current Assets||5.33 B|
|Total Current Liabilities||3.44 B||Total Debt||5.39 B||Total Liabilities||10.01 B||Total Revenue||714.13 M|
|High 52 week||18.3||Low 52 week||5.43||Last close||10.32||Last change||0.19%|
|RSI||62.45||Average true range||0.41||Beta||0.73||Volume||2.59 M|
|Simple moving average 20 days||7.05%||Simple moving average 50 days||4.64%||Simple moving average 200 days||-11.66%|
|Performance Week||9.9%||Performance Month||24.04%||Performance Quart||-39.58%||Performance Half||-15.41%|
|Performance Year||57.8%||Performance Year-to-date||41.37%||Volatility daily||2.91%||Volatility weekly||6.5%|
|Volatility monthly||13.31%||Volatility yearly||46.12%||Relative Volume||179.67%||Average Volume||3.76 M|
|New High||New Low|
2019-03-25 16:24:10 | Endo International: Wall Street Ratings Not Very Favorable?
2019-03-19 14:26:06 | Catalyst CPRX Reports Wider Q4 Loss, Focuses on Firdapse
2019-03-15 10:23:02 | BioDelivery BDSI Q4 Earnings In Line, Sales Beat, Stock Up
2019-03-14 20:06:00 | Endo International plc Announces Pricing of Private Offering Of Senior Secured Notes
2019-03-14 11:01:03 | Insys Plunges on Auditor's Concern About Insufficient Funds
2019-03-14 07:54:00 | Endo International plc Announces Debt Refinancing Transactions, Including Cash Tender Offers and Consent Solicitations for up to $1.0 billion Aggregate Purchase Price of its Outstanding Senior Notes
2019-03-14 07:51:00 | Endo International plc Announces Proposed Private Offering Of Senior Secured Notes
2019-03-12 09:35:01 | Is Endo International ENDP a Great Stock for Value Investors?
2019-03-11 13:13:34 | Opioid litigation concerns weigh on pharmaceutical loan borrowers
2019-03-11 10:30:56 | What’s Expected to Drive Endo’s Growth in Fiscal 2019?
2019-03-11 09:00:57 | Comparing Endo’s and Mallinckrodt’s Gross Margin Forecasts
2019-03-11 07:31:56 | How Endo’s and Mallinckrodt’s Expense Control Stacks Up
2019-03-08 14:40:02 | Endo International’s and Mallinckrodt’s EPS Growth Expectations
2019-03-08 13:10:02 | Comparing Endo’s and Mallinckrodt’s Revenue Forecasts
2019-03-08 11:37:59 | Analysts’ Views on Endo International and Mallinckrodt
2019-03-08 08:56:01 | Endo ENDP Soars: Stock Adds 6% in Session
2019-03-08 06:00:00 | State Pensions Fought Guns and Tobacco. Why Aren’t They Divesting From Opioids?
2019-03-07 07:35:00 | Report: Exploring Fundamental Drivers Behind Procter & Gamble, Consolidated Edison, Lennar, Endo International plc, Box, and FRONT YARD RESIDENTIAL CORP — New Horizons, Emerging Trends, and Upcoming Developments
2019-03-05 16:36:09 | What's in Store for BioSpecifics BSTC This Earnings Season?
2019-03-05 11:12:06 | FDA ruling on compounding goes Endo's way
2019-03-04 12:45:42 | Endo International plc NASDAQ:ENDP Insiders Have Been Selling
2019-03-04 08:39:01 | Implied Volatility Surging for Endo ENDP Stock Options
2019-03-04 08:00:00 | Endo to Participate at Cowen & Company 39th Annual Healthcare Conference
2019-03-01 18:04:57 | Endo gains on favorable FDA drug compounding decision
2019-03-01 15:27:00 | Endo Announces FDA Decision Not to Include Vasopressin on 503B Bulks List
2019-03-01 14:20:07 | Endo ENDP Q4 Earnings & Revenues Beat Estimates, Shares Up
2019-02-28 16:21:26 | Edited Transcript of ENDP earnings conference call or presentation 28-Feb-19 12:30pm GMT
2019-02-28 11:42:17 | Endo International plc ENDP Q4 2018 Earnings Conference Call Transcript
2019-02-28 06:30:00 | Endo Reports Fourth-Quarter And Full Year 2018 Financial Results
2019-02-21 10:31:03 | Earnings Preview: Endo International ENDP Q4 Earnings Expected to Decline
2019-02-08 08:06:41 | See what the IHS Markit Score report has to say about Endo International PLC.
2019-02-07 12:59:17 | FDA files motion to delay Endo litigation, again
2019-01-28 08:00:00 | Today's Research Reports on Trending Tickers: OPKO Health and Endo International
2019-01-25 17:22:00 | Endo to Announce Fourth-Quarter and Full-Year 2018 Financial Results
2019-01-19 08:06:27 | See what the IHS Markit Score report has to say about Endo International PLC.
2019-01-17 08:07:03 | See what the IHS Markit Score report has to say about Endo International PLC.
2019-01-15 08:06:34 | See what the IHS Markit Score report has to say about Endo International PLC.
2019-01-09 08:07:17 | See what the IHS Markit Score report has to say about Endo International PLC.
2019-01-08 11:34:11 | Albany region cities sue pharmaceutical companies over opioid epidemic
2019-01-02 11:25:00 | Government shutdown puts Endo-FDA lawsuit in limbo
2019-01-02 06:58:11 | Heron Gains on Priority Review Designation for Pain Drug
2018-12-31 08:52:01 | Options Traders Expect Huge Moves in Endo ENDP Stock